129 related articles for article (PubMed ID: 11739470)
1. NPY regulates catecholamine secretion from human adrenal chromaffin cells.
Cavadas C; Silva AP; Mosimann F; Cotrim MD; Ribeiro CA; Brunner HR; Grouzmann E
J Clin Endocrinol Metab; 2001 Dec; 86(12):5956-63. PubMed ID: 11739470
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
Spinazzi R; Andreis PG; Nussdorfer GG
Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
[TBL] [Abstract][Full Text] [Related]
3. Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells.
Rosmaninho-Salgado J; Araújo IM; Alvaro AR; Duarte EP; Cavadas C
J Neurochem; 2007 Nov; 103(3):896-903. PubMed ID: 17868303
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion.
Cavadas C; Céfai D; Rosmaninho-Salgado J; Vieira-Coelho MA; Moura E; Busso N; Pedrazzini T; Grand D; Rotman S; Waeber B; Aubert JF; Grouzmann E
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10497-10502. PubMed ID: 16798884
[TBL] [Abstract][Full Text] [Related]
5. Regulation of catecholamine release and tyrosine hydroxylase in human adrenal chromaffin cells by interleukin-1beta: role of neuropeptide Y and nitric oxide.
Rosmaninho-Salgado J; Araújo IM; Alvaro AR; Mendes AF; Ferreira L; Grouzmann E; Mota A; Duarte EP; Cavadas C
J Neurochem; 2009 May; 109(3):911-22. PubMed ID: 19309436
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y regulates catecholamine release evoked by interleukin-1beta in mouse chromaffin cells.
Rosmaninho-Salgado J; Alvaro AR; Grouzmann E; Duarte EP; Cavadas C
Peptides; 2007 Feb; 28(2):310-4. PubMed ID: 17207896
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y inhibits the nicotine-mediated release of catecholamines from bovine adrenal chromaffin cells.
Higuchi H; Costa E; Yang HY
J Pharmacol Exp Ther; 1988 Feb; 244(2):468-74. PubMed ID: 3346832
[TBL] [Abstract][Full Text] [Related]
8. Actions of neuropeptide Y on the rat adrenal cortex.
Renshaw D; Thomson LM; Carroll M; Kapas S; Hinson JP
Endocrinology; 2000 Jan; 141(1):169-73. PubMed ID: 10614636
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
10. Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells.
DiMaggio DA; Farah JM; Westfall TC
Endocrinology; 1994 Feb; 134(2):719-27. PubMed ID: 8299567
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system.
Nörenberg W; Bek M; Limberger N; Takeda K; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):337-47. PubMed ID: 7543184
[TBL] [Abstract][Full Text] [Related]
12. Antiserum against neuropeptide Y enhances the nicotine-mediated release of catecholamines from cultured rat adrenal chromaffin cells.
Shimoda K; Shen GH; Pfeiffer RF; McComb RD; Yang HY
Neurochem Int; 1993 Jul; 23(1):71-7. PubMed ID: 8369734
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II mediates catecholamine and neuropeptide Y secretion in human adrenal chromaffin cells through the AT1 receptor.
Cavadas C; Grand D; Mosimann F; Cotrim MD; Fontes Ribeiro CA; Brunner HR; Grouzmann E
Regul Pept; 2003 Mar; 111(1-3):61-5. PubMed ID: 12609750
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y modulates steroid production of human adrenal H295R cells through Y1 receptors.
Kempná P; Körner M; Waser B; Hofer G; Nuoffer JM; Reubi JC; Flück CE
Mol Cell Endocrinol; 2010 Jan; 314(1):101-9. PubMed ID: 19699258
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y and glucocorticoid secretion from guinea pig adrenal gland: an in vivo and in vitro study.
Rao NV; Macchi C; Tortorella C; Ahmad MF; Nussdorfer GG
Int J Mol Med; 2007 Sep; 20(3):345-9. PubMed ID: 17671739
[TBL] [Abstract][Full Text] [Related]
16. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
Mahapatra NR; Mahata M; Mahata SK; O'Connor DT
J Hypertens; 2006 May; 24(5):895-904. PubMed ID: 16612252
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide y gates a stress-induced, long-lasting plasticity in the sympathetic nervous system.
Wang Q; Wang M; Whim MD
J Neurosci; 2013 Jul; 33(31):12705-17. PubMed ID: 23904607
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors.
Movafagh S; Hobson JP; Spiegel S; Kleinman HK; Zukowska Z
FASEB J; 2006 Sep; 20(11):1924-6. PubMed ID: 16891622
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y (NPY)- and vasoactive intestinal peptide (VIP)-induced aldosterone secretion by rat capsule/glomerular zone could be mediated by catecholamines via beta 1 adrenergic receptors.
Bernet F; Bernard J; Laborie C; Montel V; Maubert E; Dupouy JP
Neurosci Lett; 1994 Jan; 166(1):109-12. PubMed ID: 8190350
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.
Galas L; Tonon MC; Beaujean D; Fredriksson R; Larhammar D; Lihrmann I; Jegou S; Fournier A; Chartrel N; Vaudry H
Endocrinology; 2002 May; 143(5):1686-94. PubMed ID: 11956150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
